tetano
Editor, Senior Moderator
Influenza Other Respir Viruses. 2015 Oct 27. doi: 10.1111/irv.12355. [Epub ahead of print]
[h=1]Survey of influenza and other respiratory viruses diagnostic testing in US hospitals, 2012-13.[/h] Su S[SUP]1,[/SUP][SUP]2[/SUP], Fry AM[SUP]1[/SUP], Kirley PD[SUP]3[/SUP], Aragon D[SUP]4[/SUP], Yousey-Hindes K[SUP]5[/SUP], Meek J[SUP]5[/SUP], Openo K[SUP]6[/SUP], Oni O[SUP]7[/SUP], Sharangpani R[SUP]8[/SUP], Morin C[SUP]9[/SUP], Hollick G[SUP]10[/SUP], Lung K[SUP]11[/SUP], Laidler M[SUP]12[/SUP], Lindegren ML[SUP]13[/SUP], Schaffner W[SUP]13[/SUP], Atkinson A[SUP]14[/SUP], Chaves SS[SUP]1[/SUP].
[h=3]Author information[/h]
[h=3]Abstract[/h] We sought to assess diagnostic practices for influenza and other respiratory virus in a survey of hospitals and laboratories participating in the US Influenza Hospitalization Surveillance Network in 2012-13. Of the 240 participating laboratories, 67% relied only on commercially-available rapid influenza diagnostic tests to diagnose influenza. Few reported the availability of molecular diagnostic assays for detection of influenza (26%) and other viral pathogens (≤ 20%) in hospitals and commercial laboratories. Reliance on insensitive assays to detect influenza may detract from optimal clinical management of influenza infections in hospitals. This article is protected by copyright. All rights reserved.
This article is protected by copyright. All rights reserved.
[h=4]KEYWORDS:[/h] EIP ; FluSurv-NET; Influenza; laboratory capacity; respiratory viruses
PMID: 26505742 [PubMed - as supplied by publisher]
[h=1]Survey of influenza and other respiratory viruses diagnostic testing in US hospitals, 2012-13.[/h] Su S[SUP]1,[/SUP][SUP]2[/SUP], Fry AM[SUP]1[/SUP], Kirley PD[SUP]3[/SUP], Aragon D[SUP]4[/SUP], Yousey-Hindes K[SUP]5[/SUP], Meek J[SUP]5[/SUP], Openo K[SUP]6[/SUP], Oni O[SUP]7[/SUP], Sharangpani R[SUP]8[/SUP], Morin C[SUP]9[/SUP], Hollick G[SUP]10[/SUP], Lung K[SUP]11[/SUP], Laidler M[SUP]12[/SUP], Lindegren ML[SUP]13[/SUP], Schaffner W[SUP]13[/SUP], Atkinson A[SUP]14[/SUP], Chaves SS[SUP]1[/SUP].
[h=3]Author information[/h]
[h=3]Abstract[/h] We sought to assess diagnostic practices for influenza and other respiratory virus in a survey of hospitals and laboratories participating in the US Influenza Hospitalization Surveillance Network in 2012-13. Of the 240 participating laboratories, 67% relied only on commercially-available rapid influenza diagnostic tests to diagnose influenza. Few reported the availability of molecular diagnostic assays for detection of influenza (26%) and other viral pathogens (≤ 20%) in hospitals and commercial laboratories. Reliance on insensitive assays to detect influenza may detract from optimal clinical management of influenza infections in hospitals. This article is protected by copyright. All rights reserved.
This article is protected by copyright. All rights reserved.
[h=4]KEYWORDS:[/h] EIP ; FluSurv-NET; Influenza; laboratory capacity; respiratory viruses
PMID: 26505742 [PubMed - as supplied by publisher]